Cambridge Cognition Holdings plc
https://www.cambridgecognition.com/
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cambridge Cognition Holdings plc
Improving Clinical Trials In Psychiatric Health Care
Kiri Granger, Monument Therapeutics’ chief scientific officer and executive director, and one of In Vivo’s 2022 Rising Leaders, hopes to take the company to the next level by rejecting the conventional one-size-fits-all approach to psychiatric clinical trials.
UK Biotech Monument Uses Repurposed Drugs To Target CNS Conditions
Emerging Company Profile: Monument Therapeutics’ novel approach to CNS drug development focuses on repurposing existing drugs with the aid of digital biomarkers.
Company Information
- Industry
- Digital Health
- Services
- Other Names / Subsidiaries
-
- Cambridge Cognition Ltd
- Cambridge Cognition Holdings Ltd